**Core tip:** The laparoscopic complete mesocolic excision with central vascular ligation was associated with the same quality of the resected specimen, with no differences regarding the retrieved lymphnodes, and tumor to high tie distance; the surface of the resected mesocolon was higher in the laparoscopic group. Laparoscopy was associated with a lower rate of blood transfusions, faster recovery of gastrointestinal function, and less postoperative overall complication rate. The laparoscopic approach was associated with a statistical significant better three-year overall and disease-free survival.

INTRODUCTION
============

Complete mesocolic excision (CME) with central vascular ligation (CVL) represents an extension to the colonic cancer of the already standardized resection for rectal cancer. It adheres to the same guiding principle that sharp surgical dissection, following embryological planes, with central vascular ligation, should improve oncological outcomes\[[@B1]\].

Hohenberger et al\[[@B2]\] (2007) published the technical details of a new concept termed CME and central ligation for colonic cancer. During CME with CVL for right-sided tumors, the ileocolic and right colic vessels should be ligated at their origin from the superior mesenteric artery. Transverse colon tumors require transection of the middle colic artery at its origin. Left-sided tumors require transection of the inferior mesenteric artery (IMA) at its origin from the aorta\[[@B3]\]. Using CME and CVL, Hohenberger et al\[[@B4]\] reported a reduction of the local five-year recurrence rate from 6.5% to 3.6% and an increase in the cancer-related five-year survival rate from 82.1% to 89.1%. This specimen-oriented technique is associated with the removal of more tissue compared with standard surgery, a wider distance from the tumor to the high vascular tie (131 mm *vs* 90 mm, *P* \< 0.0001), a longer length of large bowel (314 mm *vs* 206 mm, *P* \< 0.0001), a wider area of removed mesentery (19657 mm^2^ *vs* 11829 mm^2^, *P* \< 0.0001) and a greater lymph node yield (30 *vs* 18, *P* \< 0.0001)\[[@B5]\]. These differences may partially explain the higher reported survival rates with CME and CVL.

One should note the similarities between D3 lymphadenectomy, recommended as a standard of care for stage II and III colon cancer in Eastern countries, and Western CME\[[@B3],[@B6]\]. The Japanese nomenclature includes D1 as pericolic (close to the bowel wall), D2 as intermediate (along the feeding artery), and D3 as main (at the origin of the feeding artery) lymph nodes. For right-sided tumors, a D3 lymphadenectomy requires the transection of the feeding arteries next to their origin from the superior mesenteric artery. In left-sided cancers, a D3 lymphadenectomy requires transection of the IMA close to its aortic origin\[[@B7]\].

Current evidence is consistent with a faster postoperative recovery for laparoscopic colectomies compared with the open approach; the former is not associated with any negative impact regarding local recurrence and survival rates. Therefore, according to the latest National Comprehensive Cancer Network guidelines, the laparoscopic approach is preferred given access to a surgeon with experience in advanced minimally invasive procedures\[[@B8]\].

The objective of this systematic review and meta-analysis is to summarize the current evidence regarding laparoscopic CME (L-CME) and to compare its effectiveness with its open (O-CME) counterpart.

MATERIALS AND METHODS
=====================

This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement\[[@B9]\]. Electronic search, study selection, data extraction, and quality assessment was performed independently by two reviewers.

Data sources and search strategy
--------------------------------

We conducted an electronic search to identify all published randomized controlled trials (RCTs) and controlled clinical trials (CCTs) using the following databases: United States National Library of Medicine - National Institutes of Health PubMed/MEDLINE, Excerpta Medica Database, Web of Science Core Collection, Cochrane Center Register of Controlled Trails (CENTRAL), Cochrane Database of Systematic Reviews, SciELO, and Korean Journal databases from their inception until May 2017. We did not use any language restrictions. The most recent search in PubMed was performed in May 2017.

We constructed the search strategy using various combinations of terms related to CME or D3 lymphadenectomy using an open or laparoscopic approach to colon cancer. We used in different combinations the following key words: colon, cancer, complete mesocolic excision, central vascular ligation, D3 lymphadenectomy, minimally invasive, laparoscopy, open, surgery, colectomy and resection. These words were identified as truncated words in the title, abstract, or in the medical subject headings (MeSH). We additionally used electronic and manual cross-referencing to find other relevant sources. The search strategy used in PubMed/Medline was: \[colon (MeSH Terms)\] OR colonic (Title/Abstract) OR lower intestinal (Title/Abstract) OR large bowel (Title/Abstract) AND cancer (MeSH Terms) OR neoplasia (Title/Abstract) OR neoplasm (Title/Abstract) OR tumor (Title/Abstract) AND laparoscopy(MeSH Terms) OR minimally invasive (Title/Abstract) OR laparoscopic (Title/Abstract) AND complete mesocolic excision (Title/Abstract) OR central vascular ligation (Title/Abstract) OR D3 lymphadenectomy (Title/Abstract).

Trial selection
---------------

**Study eligibility criteria**: We considered RCTs and CCTs comparing open with laparoscopic CME or D3 lymphadenectomy as eligible for inclusion if they included patients with colonic cancer.

Outcome measures
----------------

**Primary outcome**: Quality of the resected specimen (lymph nodes retrieved, complete mesocolic plane excision, tumor to arterial high tie, resected mesocolon surface).

**Secondary outcomes:** Three-year and five-year overall and disease-free survival rates, recurrence of the disease, surgical data (operation time, length of the abdominal incision, conversion rate), intraoperative complications, blood loss, postoperative complications (anastomotic leakage, wound infections, overall complications), length of hospital stay, thirty-day mortality, immunologic response, quality of life, and cost.

Data extraction
---------------

Two authors\[[@B10]\] (Negoi and Hostiuc) assessed the methodological quality of the eligible trials and independently extracted data from individual studies using a data-extraction form. We extracted the following data: Year of publication, source, title, first author, contact address, criteria for patient inclusion and exclusion, sample size, baseline characteristics, and patient characteristics including mean age, sex ratio, location of the tumor, number of patients assigned to each treatment group, and details of the intervention regimens. We registered the following outcomes: One-, three- and five-year overall and disease-free survival rates, number of removed lymph nodes, length of the resected colon, resection of the mesocolic plane, operation time, length of hospital stay, number and frequency of postoperative complications, and quality of life.

Assessment of risk of bias
--------------------------

To assess the risk of bias, we used the Cochrane Collaboration tool for RCTs. This tool grades the random sequence generation, allocation concealment, blinding of participant and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other biases\[[@B11]\]. To evaluate the non-randomized trials, we used the methodological index of non-randomized studies (MINORS)\[[@B12]\]. We scored all of the 12 methodological items for non-randomized comparative studies as follows: 0 - not reported; 1 - reported but inadequate; or 2 - reported and adequate. The global ideal score for comparative (non-comparative) studies was 24.

Statistical analysis
--------------------

For statistical analysis, we used Review Manager Software 5.3.5 (The Nordic Cochrane Centre, Copenhagen, Denmark)\[[@B11]\] provided by the Cochrane Collaboration and OpenMetaAnalyst\[[@B13]\] with metaphor package\[[@B14]\] as statitstical softwares. We selected the mean difference (MD) as an effect measure for continuous data and the odds ratio (OR) for dichotomous data; we also reported the 95%CI. In cases of continuous data presented as median and range, we estimated the mean and standard deviation according to the methods described by Hozo et al\[[@B15]\]. We used Chi-square and *I^2^* statistics to assess the studies' heterogeneity and explain the total variation observed between the studies that be generated by the differences between the trials rather than the sampling error (chance). An *I^2^* value ≤ 25% indicates less heterogeneity, an *I^2^* value \> 25% but ≤ 75% indicates a moderate heterogeneity, and *I^2^* values \> 75% indicate higher heterogeneity\[[@B16]\]. We explored the reasons behind the statistical heterogeneity using sensitivity analyses and the exclusion of specific studies. We used fixed-effect model analysis for outcomes with low heterogeneity. If we found clinical heterogeneity between included studies due to differences with respect to eligibility criteria (study population), the type of surgical technique, and lacking or differing definitions of outcomes, we performed meta-analysis by applying a random-effect model (the DerSimonian-Laird method)\[[@B17]\]. We used

Begg's funnel plot and Egger's test for assessing publication bias\[[@B18]\]. The statistical significance was defined as *P* \< 0.1 in Egger's test and *P* \< 0.05 for the other statistical tests. To correct possible publication bias, we performed trim and fill analysis\[[@B19]\]. The statistical methods of this study were reviewed by Sorin Hostiuc from the Department of Legal Medicine and Bioethics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

RESULTS
=======

Description of studies
----------------------

**Results of the search:** The initial electronic and manual literature searches revealed 174 full-text articles. A total of one RCT (from Japan)\[[@B20],[@B21]\] and eleven CCTs (four from Europe and seven from Asia)\[[@B22]-[@B32]\] met the inclusion criteria for the qualitative and quantitative (meta-analysis) synthesis; these studies involved 1619 patients in L-CME and 1477 patients in O-CME. Eleven studies were published in English and one in Chinese. The reasons for exclusion in each stage of the process are shown in Figure [1](#F1){ref-type="fig"}.

![Flow diagram of the systematic literature search and study selection according to prisma statement. RCT: Randomized control trial; CCT: Controlled clinical trial.](WJGO-9-475-g001){#F1}

**Included studies:** The characteristics of the included studies are summarized in Table [1](#T1){ref-type="table"}. All of the studies were published between 2012 and 2016, the RCT being published in 2014. The sample size of the studies ranged from 23 to 533 patients. The CME or D3 lymphadenectomy was defined as dissection along the Told's fascia space and a high (apical or central) ligation of the feeding vessel. Colonic mobilization was conducted using a medial-to-lateral or a lateral-to-medial approach according to the surgeon's preference. For right-sided tumors, the vascular pedicles were divided at their origin together with removal of the draining lymph nodes along the border of the superior mesenteric vein. For left-sided tumors, removal of the central lymph nodes from the origin of the inferior mesenteric artery was performed with high ligation or with preservation of the left colic artery. In the JCOG 0404 study, the accredited surgeons had completed more than 30 laparoscopic and 30 open colorectal resections\[[@B20]\]. In all of the other studies, the procedures were performed or supervised by colorectal surgeons. Conversion to laparotomy was defined as the extension of the abdominal incision more than eight cm or as the inability to complete the dissection fully laparoscopically. The reported rate of conversion to laparotomy was between 2.82% and 7.6%\[[@B20],[@B22]-[@B32]\]. Transverse colon cancers were excluded from the JCOG 0404 study\[[@B20]\]. Storli et al\[[@B30]\] performed 9 (7.3%) transverse colectomies in the open approach but none in the laparoscopic group. In a second paper, Storli et al\[[@B22]\] published their experience regarding CME only in transverse colon cancer. Gouvas et al\[[@B31]\] managed all of the transverse colon cancers using an extended right hemicolectomy. Munkedal et al\[[@B25]\] excluded all cancers in the transverse colon or flexures from their analysis. Bae et al\[[@B26]\], Han et al\[[@B27]\], and Zhao et al\[[@B28]\] managed all cases by a right or extended right hemicolectomy. All studies exhibited remarkable similar exclusion criteria: Stage IV disease and emergency surgery. All of the studies described the technique of laparoscopic CME. Perioperative care was not described in most trials.

###### 

Characteristics of the included studies

  **Ref**.                         **Country of origin**   **Study type**                                  **Study period**   **Female** **(number, L/O)**   **Mean age (yr, L/O)**   **Intervention (L-CME) right/transverse/left location of the tumor**   **Control (O-CME) right/transverse/left location of the tumor**   **Adjuvant chemotherapy**
  -------------------------------- ----------------------- ----------------------------------------------- ------------------ ------------------------------ ------------------------ ---------------------------------------------------------------------- ----------------------------------------------------------------- ---------------------------------------------------------------------------------------
  Kim et al\[[@B23]\], 2016        South Korea             Case control, unicentre, prospective database   2008-2013          62/44                          69/67                    116/0/0                                                                99/0/0                                                            L-CME = 68 pts (58.62%), O-CME = 78 pts (78.78%), recommended to all stage II and III
  Storli et al\[[@B22]\], 2016     Norway                  Prospective non RT, unicentre                   2007-2014          22/13                          73/23                    0/33/0                                                                 0/23/0                                                            L-CME = 8 (61.5%), O-CME = 5 (62.5%), all stage III below 75 yr
  Huang et al\[[@B24]\], 2015      China                   Case control, unicentre                         2012-2013          20/21                          56/55                    53/0/0                                                                 49/0/0                                                            NR
  Yamamoto et al\[[@B20]\], 2014   Japan                   RCT, multicentre                                2004-2009          248/215                        64/64                    144/0/389                                                              156/0/368                                                         NR, recommended for all stage III
  Munkedal et al\[[@B25]\], 2014   Denmark                 Prospective nonRT, unicentre                    2008-2011          30/38                          69.1/72.9                30/0/53                                                                41/0/38                                                           NR
  Bae et al\[[@B27]\], 2014        South Korea             Case control, unicentre                         2006-2008          40/38                          64/65                    73/12/0                                                                76/9/0                                                            All stage III and II with poor prognosis
  Han et al\[[@B26]\], 2014        China                   Case control, unicentre                         2003-2010          94/67                          67/65                    177/0/0                                                                147/0/0                                                           NR, recommended for high risk stage II and stage III
  Zhao et al\[[@B28]\], 2014       China                   Case control, multicentre                       2000-2009          53/44                          61.3/64.5                89/30/0                                                                65/36/0                                                           NR, recommended for high risk stage II and stage III
  Cong et al\[[@B29]\], 2014       China                   Case control, unicentre                         2008-2011          53/45                          61.5/62.3                96/0/0                                                                 82/0/0                                                            NR
  Storli et al\[[@B30]\], 2013     Norway                  Prospective nonRT, unicentre                    2007-2010          49/60                          71.9/73.1                50/18/60 2 pts - multiple                                              35/44/42                                                          All stage III below 75 yr
  Gouvas et al\[[@B31]\], 2012     Greece                  Prospective nonRT, multicentric                 2006-2010          19/17                          62.1/66.3                7/9/33                                                                 9/9/23                                                            NR
  Sun et al\[[@B32]\], 2012        China                   Case control, unicentre                         2000-2008          58/45                          60.1/61.9                49/7/91                                                                43/9/74                                                           NR, according to stage

L-CME: Laparoscopic complete mesocolic excision; O-CME: Open complete mesocolic excision; RT: Randomized control trial; Non RT: Non randomized control trial; L/O: Laparoscopy/open groups; NR: Not reported.

The patient demographics and baseline clinical data were similar between the treatment groups; the L-CME group exhibited a mean age of 69.91 years, and the O-CME group exhibited a mean age of 65.41 years. Women comprised 46.20% and 41.23% of the L-CME and O-CME patients, respectively. None of the studies were blinded, and all of the studies were powered to demonstrate the non-inferiority of the laparoscopic approach.

**Excluded studies:** We excluded all studies in which the surgical technique did not comply with CME or D3 lymphadenectomy principles\[[@B33]-[@B42]\]. We also excluded studies based on the hand-assisted laparoscopic technique\[[@B43],[@B44]\]. Due to the probability of overlapping patients, we have excluded first report of Kim et al\[[@B45]\] which includes only T4 patients.

Risk of bias in the included studies
------------------------------------

The risk of bias in the one Japanese RCT was low in all domains\[[@B20]\]. Although blinding of patients and medical personnel was not performed in either trial, the endpoints were considered to be objective, particularly when they were supported by photos. The prospective and retrospective non-randomized studies had good MINORS scores, although the risk of selection, performance, and detection bias was high (Table [2](#T2){ref-type="table"}). As expected, the prospective observational studies\[[@B22]-[@B23],[@B25],[@B30],[@B31]\] had a higher methodological quality comparing with the retrospective studies\[[@B24],[@B26]-[@B29]\].

###### 

Quality assessment of included non-randomized controlled trials

  **Quality evaluation criteria**             **Kim et al\[[@B23]\], 2016**   **Storli et al\[[@B22]\], 2016**   **Storli et al\[[@B30]\], 2016**   **Huang et al\[[@B24]\], 2015**   **Munkedal et al\[[@B25]\], 2014**   **Bae et al\[[@B27]\], 2014**   **Han et al\[[@B26]\], 2014**   **Zhao et al\[[@B28]\], 2014**   **Cong et al\[[@B29]\], 2014**   **Gouvas et al\[[@B31]\], 2012**   **Sun et al\[[@B32]\], 2012**
  ------------------------------------------- ------------------------------- ---------------------------------- ---------------------------------- --------------------------------- ------------------------------------ ------------------------------- ------------------------------- -------------------------------- -------------------------------- ---------------------------------- -------------------------------
  Clear stated aim                            2                               2                                  2                                  2                                 2                                    2                               2                               2                                2                                2                                  2
  Inclusion of consecutive patients           2                               2                                  2                                  2                                 2                                    2                               2                               2                                1                                2                                  2
  Prospective data collection                 2                               2                                  2                                  0                                 2                                    0                               0                               0                                0                                2                                  0
  Endpoints appropriate to the study aim      2                               2                                  2                                  2                                 2                                    2                               2                               2                                2                                2                                  2
  Unbiased assessment of study end-point      2                               2                                  2                                  2                                 2                                    2                               2                               1                                1                                2                                  1
  Appropriate follow-up period                2                               2                                  2                                  1                                 2                                    2                               2                               2                                2                                2                                  2
  Loss to follow-up less than 5%              1                               2                                  2                                  1                                 2                                    2                               2                               1                                1                                2                                  1
  Prospective calculation of the study size   0                               0                                  0                                  0                                 0                                    0                               0                               0                                0                                0                                  0
  Adequate group control                      2                               2                                  2                                  2                                 2                                    2                               2                               2                                0                                2                                  2
  Contemporary groups                         2                               2                                  2                                  2                                 2                                    2                               2                               2                                2                                2                                  2
  Baseline equivalence                        2                               2                                  2                                  2                                 2                                    2                               2                               2                                2                                2                                  2
  Adequate statistical analysis               2                               2                                  2                                  2                                 2                                    2                               2                               2                                2                                2                                  1
  Total                                       21                              22                                 22                                 18                                22                                   20                              20                              18                               15                               22                                 17

0: Non-reported; 1: Reported but inadequate; 2: Reported and adequate.

Effects of intervention
-----------------------

**Overall survival:** Three-year overall survival was reported by four studies, including 1010 patients (Table [3](#T3){ref-type="table"}). The laparoscopic approach was associated with a statistical significant better three-year overall survival, with an OR of 2.02 (95%CI: 1.31 to 3.12, *P* = 0.001, *I^2^* = 28%). The five-year overall survival was reported by three studies, with a high heterogeneity between them (*I^2^* = 63%). The combined data revealed no statistical significant differences between the L-CME and O-CME (OR = 0.77, *P* = 0.38, 95%CI: 0.44 to 1.37) (Figure [2](#F2){ref-type="fig"}). Meta-regression of studies on three-year overall survival according to the number of included patients revealed a trend, although not statistical significant (omnibus *P* = 0.127), for decreasing of the size of the effect with increasing the number of patients (Figure [3A](#F3){ref-type="fig"}). The subgroup analysis of studies that include or not only right sided colon cancers, reveled statistical significant results irrespective of that (*P* = 0.003 and *P* = 0.018, respectively) (Figure [3B](#F3){ref-type="fig"}). On the other hand, the cumulative meta-analysis showed a progressively increasing of the size effect while experience is accumulating (Figure [3C](#F3){ref-type="fig"}).

![Meta-analysis of studies on overall survival of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g002){#F2}

###### 

Results of meta-analysis comparing laparoscopic with open complete mesocolic excision for colon cancer

  **Outcome or subgroups**             **No. of Studies**   **Participants**   **Statistical method (95%CI)**   **Effect estimate (95%CI)**   ***P* value**   **Heterogeneity *P*, I2 (%)**
  ------------------------------------ -------------------- ------------------ -------------------------------- ----------------------------- --------------- -------------------------------
  Survival and recurrences                                                                                                                                    
  Overall survival                     6                    1777               OR (M-H, random)                 1.32 (0.83, 2.10)             0.24            0.002, 70
  Three-year                           4                    1010               OR (M-H, random)                 2.02 (1.31, 3.12)             0.001           0.24, 28
  Five-year                            3                    767                OR (M-H, random)                 0.77 (0.44, 1.37)             0.38            0.07, 63
  Disease free survival                4                    856                OR (M-H, random)                 1.15 (0.70, 1.87)             0.58            0.09, 54
  Three-year                           3                    686                OR (M-H, random)                 1.45 (1.00, 2.10)             0.05            0.89, 0
  Five-year                            1                    170                OR (M-H, random)                 0.50 (0.24, 1.05)             0.07            NA
  Local recurrences                    5                    1233               OR (M-H, fixed)                  0.67 (0.38, 1.17)             0.16            0.60, 0
  One-year                             2                    466                OR (M-H, fixed)                  0.52 (0.20, 1.35)             0.18            0.30, 7
  Five-year                            3                    767                OR (M-H, fixed)                  0.77 (0.38, 1.54)             0.46            0.52, 0
  Distant recurrences                  4                    1018               OR (M-H, random)                 0.98 (0.61, 1.58)             0.94            0.17, 40
  Three-year                           1                    251                OR (M-H, random)                 1.28 (0.54, 3.03)             0.58            NA
  Five-year                            3                    767                OR (M-H, random)                 0.90 (0.48, 1.69)             0.75            0.10, 57
  Port site metastasis                 2                    494                OR (M-H, fixed)                  1.52 (0.20, 11.42)            0.69            0.55, 0
  Quality of the resected specimen                                                                                                                            
  Lymphnodes retrieved                 10                   2647               MD (IV, random)                  -1.06 (-3.65, 1.53)           0.42            \< 0.001, 92
  RCTs                                 1                    1057               MD (IV, random)                  1.00 (-0.34, 2.34)            0.14            NA
  NRCTs                                9                    1590               MD (IV, random)                  -1.32 (-4.42, 1.78)           0.40            \< 0.001, 92
  Lymphnodes retrieved                 10                   2647               MD (IV, random)                  -1.06 (-3.65, 1.53)           0.42            \< 0.001, 92
  \< 100 patients                      4                    478                MD (IV, random)                  -3.18 (-8.69, 2.33)           0.26            \< 0.001, 85
  \> 100 patients                      6                    2169               MD (IV, random)                  0.29 (-1.64, 2.21)            0.77            \< 0.001, 83
  Lymphnodes retrieved                 10                   2647               MD (IV, random)                  -1.06 (-3.65, 1.53)           0.42            \< 0.001, 92
  Europe                               4                    559                MD (IV, random)                  -3.33 (-8.31, 1.64)           0.19            \< 0.001, 90
  Asia                                 6                    2088               MD (IV, random)                  0.56 (-1.33, 2.46)            0.56            \< 0.001, 77
  Tumor to arterial high tie (mm)      2                    252                MD (IV, random)                  14.26 (-4.30, 32.82)          0.13            \< 0.001, 92
  Resected mesocolon surface (cm^2^)   2                    252                MD (IV, fixed)                   11.75 (9.50, 13.99)           \< 0.001        0.55, 0
  Complete mesocolic plane excision    1                    90                 OR (M-H, fixed)                  0.77 (0.20, 2.96)             0.71            NA
  Operative data                                                                                                                                              
  Duration of surgery                  7                    2266               MD (IV, random)                  26.26 (5.06, 47.46)           0.02            \< 0.001, 94
  Incision length (cm)                 2                    1159               MD (IV, random)                  -14.01 (-14.35, -13.66)       \< 0.001        0.89, 0
  Blood loss (mL)                      5                    1868               MD (IV, random)                  -52.11 (-78.57, -25.65)       \< 0.001        \< 0.001, 89
  Transfusion requirement              2                    1272               OR (M-H, random)                 0.45 (0.27, 0.75)             0.002           0.54, 0
  Intraoperative morbidity             1                    1057               OR (M-H, fixed)                  2.12 (0.95, 4.72)             0.07            NA
  Postoperative course                                                                                                                                        
  Time to first flatus (d)             4                    1771               MD (IV, random)                  -0.90 (-1.46, -0.34)          0.002           \< 0.001, 97
  Time to liquid diet (d)              5                    1031               MD (IV, random)                  -1.84 (-2.93, -0.74)          0.001           \< 0.001, 98
  Short-term morbidity and mortality                                                                                                                          
  Thirty-day overall morbidity         7                    2144               OR (M-H, fixed)                  0.57 (0.46, 0.71)             \< 0.001        0.76, 0
  RCTs                                 1                    1057               OR (M-H, fixed)                  0.66 (0.49, 0.89)             0.006           NA
  NRCTs                                6                    1087               OR (M-H, fixed)                  0.49 (0.36, 0.68)             \< 0.001        0.89, 0
  Wound complications                  8                    2322               OR (M-H, fixed)                  0.43 (0.30, 0.61)             \< 0.001        0.80, 0
  Postoperative bleeding               4                    1662               OR (M-H, fixed)                  1.20 (0.46, 3.12)             0.71            0.75, 0
  Pneumonia                            5                    867                OR (M-H, random)                 0.61 (0.20, 1.84)             0.38            0.21, 32
  Anastomotic leakage                  8                    2471               OR (M-H, fixed)                  0.82 (0.54, 1.25)             0.36            0.77, 0
  Need for reoperation                 2                    1113               OR (M-H, fixed)                  0.59 (0.28, 1.23)             0.16            0.79, 0
  Thirty-day mortality                 6                    2237               OR (M-H, fixed)                  0.42 (0.16, 1.12)             0.07            0.98, 0
  Hospital stay (d)                    9                    2573               MD (IV, random)                  -4.07 (-5.87, -2.28)          \< 0.001        \< 0.001, 91

M-H: Mantel-haenszel analysis method; IV: Inverse variance analysis method; RCT: Randomized control trial; NRCs: Non-randomized control trials; MD: Mean difference; OR: Odds ratio; NA: Not applicable.

![Results of statistical analysis. A: Meta-regression on three-year overall survival according with the number of included patients in each study, of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer; B: Subgroup meta-analysis according with the selection of patients with only right colon cancers (Yes group) or all-localizations colon cancer (No group); C: Cumulative meta-analysis according to the year of publishing for each study.](WJGO-9-475-g003){#F3}

Disease-free survival
---------------------

Three studies, with a total of 686 patients, reported the three-year DFS with a low heterogeneity between them (*I^2^* = 0%). However, to adjust for possible methodological differences we used the random-effects model, which revealed that the laparoscopic approach is associated with a statistical significant better three-year DFS (OR = 1.45, 95%CI: 1.00 to 2.10, *P* = 0.05) (Figure [4](#F4){ref-type="fig"}). Meta-regression of studies on three-year overall survival according to the number of the included patients revealed a trend, although not statistical significant (Omnibus *P* = 0.718), for decreasing of the size of the effect with increasing the number of patients (Figure [5](#F5){ref-type="fig"}).

![Meta-analysis of studies on disease-free survival of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g004){#F4}

![Meta-regression of studies on three-year disease-free survival of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g005){#F5}

Local and distant recurrences
-----------------------------

The local recurrence rate was presented by five studies, including 1233 patients. In the fixed-effect meta-analysis there were no statistical significant differences between L-CME and O-CME (OR = 0.67, 95%CI: 0.38 to 1.17, *P* = 0.16, *I^2^* = 0%) (Figure [6](#F6){ref-type="fig"}).

![Meta-analysis of studies local recurrence rate of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g006){#F6}

The distant recurrence rate was presented by four studies, with a moderate heterogeneity between them (*I^2^* = 40%). In the random-effects meta-analysis there were no statistical significant differences between the two groups (OR = 0.98, 95%CI: 0.61 to 1.58, *P* = 0.94). Using Egger's test, no publication bias was found for local (*t* = 0.22, *P* = 0.42) or distant recurrences (*t* = 0.38, *P* = 0.36).

The port size metastasis rate was reported by two studies including 494 patients, with a low heterogeneity between them (*I^2^* = 0%). In the fixed-effect analysis model there was no difference regarding the port size metastasis rate between laparoscopic and open CME (OR = 1.52, 95%CI: 0.20 to 11.42, *P* = 0.69).

Quality of the resected specimen
--------------------------------

Standardized evaluation of the resected specimen and grading its quality are objective measures that predict recurrence rate and survival. These data are correlated with the accuracy of the surgical technique.

Lymphnodes retrieved
--------------------

Ten studies reported the number of retrieved lymph nodes for 1376 L-CME patients and 1271 O-CME patients. There was a high heterogeneity between the studies (*I^2^* = 92%). In the random-effects model, we found no statistically significant mean difference between L-CME and O-CME (MD = -1.06, 95%CI: -3.65 to 1.53, *P* = 0.42) (Figure [7](#F7){ref-type="fig"}). In order to address the observed heterogeneity, we performed subgroup analysis according to the number of included patients (less or more than 100 patients in each group) and the geographical location of the study (Europe and Asia). The subgroup analysis revealed a high heterogeneity between studies with less than (*I^2^* = 85%) or more (*I^2^* = 83%) than 100 patients into laparoscopy or open group. The results remained with no statistical significance into the two subgroups. Studies coming from Europe showed a high heterogeneity (*I^2^* = 90%) and with no differences regarding the number of retrieved lymphnodes (*P* = 0.19). Studies published in Asia had also a high heterogeneity (*I^2^* = 77%), and no statistical significant difference between L-CME and O-CME (*P* = 0.56). Meta-regression of retrieved lymphnodes according to the number of patients revealed that the equivalence between laparoscopic and open approach is stronger with the increased experience in laparoscopic approach (number of the included patients - omnibus *P* = 0.314, Figure [8A](#F8){ref-type="fig"}; and year of publishing of the study, Figure [8B](#F8){ref-type="fig"}).

![Meta-analysis of studies on lymphnodes retrieved of the specimen of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g007){#F7}

![Results of statistical analysis. A: Meta-regression of studies on lymphnodes retrieved of the specimen according to the number of the included patients in each study; B: Cumulative meta-analysis according to the year of publishing of the article of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g008){#F8}

Tumor to high tie distance
--------------------------

The mean distance from the tumor to the arterial high tie was reported by two studies that included 132 patients in the L-CME group and 120 patients in the O-CME group; we noted high heterogeneity among the studies (*I^2^* = 92%). Using the random-effects model, we did not find any statistically significant difference between the L-CME and O-CME groups (MD = 14.26 cm, 95%CI: -4.30 to 32.82, *P* = 0.13) (Figure [9](#F9){ref-type="fig"}).

![Meta-analysis of studies on tumor to arterial high tie (mm) distance of the specimen of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g009){#F9}

Surface of the resected mesocolon
---------------------------------

The surface of the resected mesocolon was reported by two studies with 132 patients in the L-CME group and 120 patients in the O-CME group. The surface of the resected mesocolon was larger in the L-CME group (MD = 11.75 cm^2^, 95%CI: 9.50 to 13.99, *P* \< 0.001) (Figure [10](#F10){ref-type="fig"}).

![Meta-analysis of studies on resected mesocolon surface (cm^2^) of the specimen of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g010){#F10}

Complete mesocolic plane excision rate
--------------------------------------

One study reported the rate of complete mesocolic plane excision, with no statistically significant difference between the laparoscopic and open approach (OR = 0.77, 95%CI: 0.20 to 2.96).

Duration of surgery
-------------------

The duration of surgery was reported by seven studies, with a high heterogeneity between data (*I^2^* = 94%). The L-CME group had a longer duration of surgery with a mean difference of 26.26 min (95%CI: 5.06 to 47.46, *P* = 0.02). Using Egger's test, no publication bias was found (*t* = 0.71, *P* = 0.26).

Incision length
---------------

The incision length was reported by two studies, including 586 patients in the L-CME group and 573 patients in the O-CME group. Patients from the laparoscopic group had a shorter incision, with a mean difference of 14.01 cm (95%CI: -14.35 to -13.66, *P* \< 0.001).

Blood loss
----------

Intraoperative blood-loss data were presented by five studies, with 964 and 904 patients in the L-CME and O-CME, respectively. Due to the high heterogeneity of the data (*I^2^* = 89%) we have used the random-effect analysis. The laparoscopic approach was associated with statistical significant lower intraoperative bleeding, with a mean difference of 52.11 mL (95%CI: -78.57 to -25.65, *P* \< 0.001). Using Egger's test, no publication bias was found (*t* = 0.17, *P* = 0.44). Should be noted the clinical significance of lower intraoperative blood loss associated with laparoscopic approach, which was translated in a lower need for transfusion rate (OR = 0.45, 95%CI: 0.27 to 0.75, *P* = 0.002). Two studies, including a total of 1272 patients, reported the need for blood transfusions, with a low heterogeneity between them (*I^2^* = 0%) (Figure [11](#F11){ref-type="fig"}).

![Meta-analysis of studies on transfusion requirements of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g011){#F11}

Recovery of gastrointestinal function
-------------------------------------

The time to first flatus was reported by four studies, including 914 and 857 patients in the L-CME and O-CME, respectively. In the random-effects meta-analysis the laparoscopic approach was associated with a shorter time interval to first flatus, with a mean difference of 0.90 d (95%CI: -1.46 to -0.34, *P* = 0.002, *I^2^* = 97%).

The time to liquid diet was reported by five studies, with a high heterogeneity between them (*I^2^* = 98%). The time to liquid diet was shorter for the L-CME patients, with a mean difference of 1.84 d (95%CI: -2.93 to -0.74, *P* = 0.001).

Short-term morbidity and mortality
----------------------------------

Seven studies presented the postoperative overall morbidity, and these studies included 1116 patients in the L-CME group and 1028 patients in the O-CME group. There was low statistical heterogeneity among the studies (*I^2^* = 0%). The L-CME procedure was associated with a lower postoperative morbidity (OR = 0.57, 95%CI: 0.46 to 0.71, *P* \< 0.001) (Figure [12](#F12){ref-type="fig"}).

![Meta-analysis of studies on postoperative overall morbidity of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g012){#F12}

Wound complications, reported by eight studies, were significantly less frequent in the L-CME group (OR = 0.43, 95%CI: 0.30 to 0.61, *P* \< 0.001). There was no statistical heterogeneity among the studies (*I^2^* = 0%).

There was no difference between the two groups regarding postoperative bleeding (OR = 1.20, 95%CI: 0.46 to 3.12, *P* = 0.71), anastomotic leakage (OR = 0.82, 95%CI: 0.0.54 to 1.25, *P* = 0.36), need for reoperation (OR = 0.59, 95%CI: 0.28 to 1.23, *P* = 0.16), and pulmonary complications (OR = 0.61, 95%CI: 0.20 to 1.84, *P* = 0.38).

The 30-d mortality was reported by six studies with 1158 patients in the L-CME group and 1079 patients in the O-CME group. There was low heterogeneity among the studies (*I^2^* = 0%). In the fixed-effects meta-analysis we observed no statistically significant difference between the L-CME and O-CME groups (OR = 0.42, 95%CI: 0.16 to 1.12).

Nine studies, with 1340 and 1233 patients in the L-CME and O-CME, respectively reported the hospital stay. There was a high heterogeneity between the studies (*I^2^* = 91%). In the random-effects meta-analysis we found a statistical significant lower hospital stay for laparoscopic group, with a mean difference of 4.07 d (95%CI: -5.87 to -2.28, *P* \< 0.001).

Risk of bias across studies
---------------------------

We conducted sensitivity analysis to assess statistical heterogeneity based on excluding specific studies with a high risk of bias (Figure [13](#F13){ref-type="fig"}). There were no relevant changes in the overall effects of the quantitative synthesis. Our analysis of the funnel plots reveals no significant asymmetries for the studied outcomes (Figures [14](#F14){ref-type="fig"} and [15](#F15){ref-type="fig"}).

![Leave-one-out meta-analysis for the endpoint number of retrieved lymphnodes of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g013){#F13}

![Begg's funnel plot for the endpoint number of retrieved lymphnodes of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer. RCTs: Randomized control trial; NRCTs: Non-randomized clinical studies.](WJGO-9-475-g014){#F14}

![Begg's funnel plot for the endpoint overall survival of patients undergoing laparoscopic *vs* open complete mesocolic excision with central vascular ligation excision for colon cancer.](WJGO-9-475-g015){#F15}

DISCUSSION
==========

Our meta-analysis revealed that laparoscopic CME with CVL for colon cancer offers the same quality of the resected specimen as the open approach, being superior in all perioperative results and at least non-inferior in long-term oncological outcomes. Although not addressed the complete mesocolic excision or D3 lymphadenectomy technique, the equivalence of laparoscopy in terms of resected lymphnodes was showed in four large, multicenter, studies-Clinical Outcomes of Surgical Therapy (COST), Conventional *vs* Laparoscopic-Assisted Surgery in Colorectal Cancer (CLASSIC), Colon Cancer Laparoscopic or Open Resection I (COLOR I), and the Australasian Randomized Clinic Study Comparing Laparoscopic and Conventional Open Surgical Treatments for Colon Cancer (ALCCaS); the mean number of resected lymph nodes was 10.13 in the laparoscopic group and 10.14 in the open group\[[@B40]-[@B42]\]. An RCT from Taiwan comparing open with laparoscopic left-sided D2 resections for stage II or III colon cancer reported 16 ± 3 dissected lymph nodes in its laparoscopic group and 16 ± 6 in its open group\[[@B33]\]. The long-term oncological outcomes between the L-CME and O-CME groups were also comparable; there were no differences regarding the local and distant recurrence rate, the three- and five-year overall rates and the disease-free survival rates. In our study, the three-year overall and disease-free survival were superior in the laparoscopic group; however, should be noted the extensive experience in laparoscopy of the reporting centers. In Barcelona study, the laparoscopic approach was associated with a slight increase in survival rate, a faster postoperative recovery, and a shorter in-hospital stay duration\[[@B38]\]. In the COLOR study, 1248 patients were randomized for open or laparoscopic colon resection\[[@B46]\]. After a median follow-up of 53 mo, the combined three-year, disease-free survival rate was 74.2% in the laparoscopic group and 76.2% in the open group (*P* = 0.70). The combined three-year overall survival rate was 81.8% in the laparoscopic group and 84.2% in the open group (*P* = 0.45). The authors concluded that a difference in the three-year, disease-free survival rate could not be ruled out due to limitations of the study\[[@B46]\]. In the CLASSIC trial, 794 patients with colorectal cancer were randomized for open or laparoscopic resection\[[@B47]\]. An analysis of the subgroup of patients with colon cancer, 140 in the open group and 273 in the laparoscopic group, did not reveal any differences in terms of three-year overall survival rates (*P* = 0.51). After a median follow-up of 62.9 mo, there were no statistically significant differences in overall survival and disease-free survival rates\[[@B48]\]. In the COST study, 872 patients were randomized to receive an open or laparoscopic colectomy\[[@B49]\]. The 3- and 5-year follow-ups revealed no differences regarding recurrence rate and overall survival rates\[[@B49],[@B50]\].

We found a longer duration of surgery in the laparoscopic group. However, all the perioperative outcomes, such as blood loss, need for transfusion, incision length, wound complications, and thirty-day overall morbidity were less frequent in the laparoscopic group. In the COST, CLASSIC, COLOR I, and ALCCaS trials, the mean duration of surgery was 145-180 compared to 95-135 min, the hospital stay was 5-10 *vs* 6-11 d, the 30-d morbidity was 21%-38% *vs* 20%-45%, and the 30-d mortality was 0.5%-4.0% *vs* 0.7%-5.0% in the laparoscopic and open groups, respectively\[[@B40]-[@B42],[@B49]\]. Liang et al\[[@B33]\] found a longer operative time for left-sided resections (224.4 ± 44.8 min *vs* 184.0 ± 30.6 min), less blood loss (54 ± 12 mL *vs* 240 ± 34 mL), a shorter wound incision (10.6 ± 1.6 cm *vs* 18 ± 3.1 cm) for the laparoscopic approach, but there were no statistically significant differences regarding total postoperative complications (20 *vs* 29, *P* = 0.15).

Our meta-analysis showed that patients from the laparoscopic group had a shorter hospital stay and a shorter recovery time to regain gastrointestinal function. This result is consistent with the current evidence that supported earlier recovery of bowel functioning and oral diet with an in-hospital stay duration 1.7 d shorter in the laparoscopic group\[[@B51]\]. The studies included in the current meta-analysis did not evaluate how surgery affected immune functioning. According to Liang et al\[[@B33]\], the postoperative proinflammatory response, evaluated by C-reactive protein and the erythrocyte sedimentation rate and postoperative immunosuppression and assessed by alteration of lymphocyte counts and the CD4^+^/CD8^+^ ratio, was significantly less in the laparoscopic group (*P* \< 0.001).

An important concern regarding laparoscopic colon surgery is the reproducibility of results given the nature of multicenter, specialized centers and the heterogeneity of general surgeons. All surgical procedures from the studies included in this meta-analysis were performed by highly experienced or accredited surgeons. An analysis of the short-term outcomes of colon and rectal laparoscopic resections in Sydney South West Area Health Service revealed a lower morbidity (28.8% *vs* 54.4%, *P* \< 0.001), fewer transfusions (0.4 units *vs* 0.7 units, *P* = 0.0028), a longer operative time (24.1 min, *P* \< 0.0001) and a shorter length of stay (7 *vs* 10 d, *P* = 0.0011) for laparoscopic procedures\[[@B52]\]. Dobbins et al\[[@B53]\] published the results of laparoscopic resections for colon and rectal cancer from all of the public and private hospitals in New South Wales, Australia. The laparoscopic colon resections were associated with a reduced rate of extended stay (OR = 0.60, 95%CI: 0.49-0.72) and 28-d readmissions (OR = 0.86, 95%CI: 0.74-0.99). Survival benefits for laparoscopy, regarding cancer-specific survival, were observed in higher-caseload hospitals but not in lower-caseload hospitals\[[@B53]\].

The current meta-analysis has as a main limitation the clinical heterogeneity of the included studies, and caution should be exercised when interpreting its results. This meta-analysis involves several types of study designs, including retrospective, prospective, and RCT. There is an increased heterogeneity of the tumor localization on the colon, with the transverse colon cancers being excluded from the analysis in two studies, while the others included them into the right/extended right hemicolectomy group. Excepting the one randomized controlled trial, the experience in minimally invasive surgery of the surgeons from the laparoscopic group is not quantified, although all procedures were performed or supervised by trained colorectal surgeons. However, using random-effects meta-analysis, with subgroup analysis and meta-regression, we limited the variance of the included outcomes.

In summary, the current data suggest that the laparoscopic approach offers the same quality of resected specimens as the open approach in CME with CVL for colon cancer while maintaining all of the short-term benefits of a minimally invasive approach. Although a specimen-oriented surgical dissection in colon cancer *via* a laparoscopic approach is challenging, the magnification and predisposition to details of a minimally invasive technique are associated with a lower postoperative morbidity.

COMMENTS
========

Background
----------

Complete mesocolic excision with central vascular ligation represents an extension to the colonic cancer of the already standardized resection for rectal cancer. It adheres to the same guiding principle that sharp surgical dissection, following embryological planes, with central vascular ligation, should improve oncological outcomes. The technical details of this new concept were published in 2007.

Research frontiers
------------------

A high-level evidence that laparoscopic approach offers the same quality of the resected specimen as open surgery for complete mesocolic excision with central vascular ligation for colon cancer is lacking.

Innovations and breakthroughs
-----------------------------

Current evidence is consistent with a faster postoperative recovery for laparoscopic colectomies compared with the open approach; the former is not associated with any negative impact regarding local recurrence and survival rates. This study reveals that laparoscopy offers the same quality of the resected specimen as the open approach in complete mesocolic excision with central vascular ligation for colon cancer. The laparoscopic complete mesocolic excision with central vascular ligation is superior in all perioperative results and at least non-inferior in long-term oncological outcomes.

Applications
------------

Due to all advantages of laparoscopy, the teaching and mentoring of minimally invasive techniques for colon resections should be accentuated, in order to increase the proportion of laparoscopic over open procedures.

Terminology
-----------

During complete mesocolic excision with central vascular ligation for right-sided tumors, the ileocolic and right colic vessels should be ligated at their origin from the superior mesenteric artery, medial (patient left-hand side) to the superior mesenteric vein. Transverse colon tumors require transection of the middle colic artery at its origin. Left-sided tumors require transection of the inferior mesenteric artery at its origin from the aorta.

Peer-review
-----------

This is an interesting meta-analysis and review of a highly debatable topic in surgery, the consensus about laparoscopic *vs* open surgery in high ligation.
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